Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response.
作者信息
Midtvedt Karsten, Vaage John Torgils, Heldal Kristian, Munthe Ludvig A, Lund-Johansen Fridtjof, Åsberg Anders
机构信息
Department of Transplantation Medicine, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
出版信息
Am J Transplant. 2022 Nov;22(11):2704-2706. doi: 10.1111/ajt.17091. Epub 2022 May 19.
Abstract
摘要
相似文献
1
Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response.先前体液抗体反应受损的肾移植受者接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗第四剂。
Am J Transplant. 2022 Nov;22(11):2704-2706. doi: 10.1111/ajt.17091. Epub 2022 May 19.
2
Antibody Response to SARS-CoV-2 mRNA Vaccine Among Kidney Transplant Recipients.肾移植受者对SARS-CoV-2 mRNA疫苗的抗体反应
Exp Clin Transplant. 2022 Nov;20(11):1048. doi: 10.6002/ect.2022.0176.
3
Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.肾移植受者同源与异源第三剂疫苗接种后 4 周时的 SARS-CoV-2 抗体反应比较：一项随机临床试验。
JAMA Intern Med. 2022 Feb 1;182(2):165-171. doi: 10.1001/jamainternmed.2021.7372.
4
A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients.mRNA-1273新冠病毒疫苗的第四剂增强了肾移植受者血清对德尔塔变异株的中和作用。
Kidney Int. 2022 May;101(5):1073-1076. doi: 10.1016/j.kint.2022.02.011. Epub 2022 Feb 26.
5
Delayed kinetics of SARS-CoV-2 IgG antibody production in kidney transplant recipients following the third dose of COVID-19 vaccination.肾移植受者在接种第三剂新冠疫苗后，新冠病毒2型免疫球蛋白G抗体产生的动力学延迟
Clin Exp Nephrol. 2023 Jan;27(1):98-99. doi: 10.1007/s10157-022-02261-6. Epub 2022 Aug 5.
6
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
7
Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An Update.实体器官移植受者对第四剂SARS-CoV-2疫苗的抗体反应：最新情况
Transplantation. 2022 Jul 1;106(7):e338-e340. doi: 10.1097/TP.0000000000004137. Epub 2022 Apr 15.
8
Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.肾移植受者在接种第三剂mRNA疫苗后对新冠病毒奥密克戎变异株的抗体反应欠佳。
Kidney Int. 2022 Jun;101(6):1282-1286. doi: 10.1016/j.kint.2022.04.009. Epub 2022 Apr 13.
9
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine.移植前接种疫苗的肾移植受者对 SARS-CoV-2 疫苗保持优越的体液反应。
Clin Transplant. 2021 Dec;35(12):e14478. doi: 10.1111/ctr.14478. Epub 2021 Sep 29.
10
Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients.在接受mRNA疫苗初免的肾移植受者中，第三剂异源载体疫苗Ad26.COVS1接种后SARS-CoV-2抗体反应增强。
Transpl Int. 2022 Mar 22;36:10357. doi: 10.3389/ti.2022.10357. eCollection 2022.
引用本文的文献
1
Immunosuppressive Therapy Modifies Anti-Spike IgG Subclasses Distribution After Four Doses of mRNA Vaccination in a Cohort of Kidney Transplant Recipients.免疫抑制疗法改变了一组肾移植受者在四剂 mRNA 疫苗接种后的抗刺突 IgG 亚类分布。
Vaccines (Basel). 2025 Jan 25;13(2):123. doi: 10.3390/vaccines13020123.
2
Effects of antineoplastic and immunomodulating agents on postvaccination SARS-CoV-2 breakthrough infections, antibody response, and serological cytokine profile.抗肿瘤和免疫调节剂对疫苗突破性 SARS-CoV-2 感染、抗体反应和血清细胞因子谱的影响。
J Immunother Cancer. 2024 Jan 31;12(1):e008233. doi: 10.1136/jitc-2023-008233.
3
Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.实体器官移植受者对 SARS-CoV-2 感染的易感性和对 COVID-19 疫苗接种的免疫反应。
J Infect Dis. 2023 Aug 4;228(Suppl 1):S34-S45. doi: 10.1093/infdis/jiad152.
4
Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort study.新冠疫情期间肾移植受者的体液疫苗反应和突破性感染：一项全国性队列研究
EClinicalMedicine. 2023 Jun;60:102035. doi: 10.1016/j.eclinm.2023.102035. Epub 2023 Jun 6.
5
Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review.肾移植受者额外接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗剂量的有效性、免疫原性和危害：一项系统评价
Vaccines (Basel). 2023 Apr 18;11(4):863. doi: 10.3390/vaccines11040863.
6
Humoral response after a fourth dose of SARS-CoV-2 vaccine in immunocompromised patients. Results of a systematic review.免疫功能低下患者接种第四剂 SARS-CoV-2 疫苗后的体液反应。系统评价结果。
Front Public Health. 2023 Mar 23;11:1108546. doi: 10.3389/fpubh.2023.1108546. eCollection 2023.
7
Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine dose.肾移植受者接种第三剂 mRNA 疫苗后持续存在的 SARS-CoV-2 特异性免疫缺陷。
Am J Transplant. 2023 Jun;23(6):744-758. doi: 10.1016/j.ajt.2023.03.014. Epub 2023 Mar 24.
8
Efficacy and safety of booster vaccination against SARS-CoV-2 in dialysis and renal transplant patients: systematic review and meta-analysis.透析和肾移植患者接种 SARS-CoV-2 加强疫苗的疗效和安全性：系统评价和荟萃分析。
Int Urol Nephrol. 2023 Apr;55(4):791-802. doi: 10.1007/s11255-023-03471-x. Epub 2023 Feb 1.
9
High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant Recipients.肝移植受者对 BNT162b2 疫苗第四针加强针针对关注的奥密克戎变异株的高免疫应答率。
Viruses. 2022 Dec 12;14(12):2769. doi: 10.3390/v14122769.
10
Humoral and Cellular Response of Transplant Recipients to a Third Dose of mRNA SARS-CoV-2 Vaccine: A Systematic Review and Meta-analysis.移植受者对第三剂 mRNA SARS-CoV-2 疫苗的体液和细胞反应：系统评价和荟萃分析。
Transplantation. 2023 Jan 1;107(1):204-215. doi: 10.1097/TP.0000000000004386. Epub 2022 Nov 4.
Zotero 插件